Literature DB >> 23627928

Seroepidemiology of predominant norovirus strains circulating in Korea by using recombinant virus-like particle antigens.

Hosun Son1, Hye Sook Jeong, Miyoung Cho, Jungsoo Lee, Hoekyu Lee, Kibok Yoon, Ah-Yong Jeong, Sunyoung Jung, Kyungjin Kim, Doo-Sung Cheon.   

Abstract

An epidemiological survey on human norovirus (NoV)-associated gastroenteritis was conducted to clarify the prevalence of NoV infections in children and adults in Korea. Recombinant capsid proteins from three major NoV genotypes (GI-4, GII-3, and GII-4) were expressed using a baculovirus expression system, and the morphology and antigenicity of self-assembled virus-like particles were then confirmed by electron microscopy and Western blotting with a NoV-specific antibody. To determine seroprevalence, an enzyme-linked immunosorbent assay was performed to detect antibodies against virus-like particles antigen in 346 serum specimens collected from persons who visited five public heath care centers for regular physical examination in Jeollanam-do, Korea, between 2005 and 2006. The seroprevalence of immunoglobulin G antibodies against the GI-4, GII-3, and GII-4 NoV genotypes was 84.1%, 76.3%, and 94.5%, respectively. A rapid decrease in seroprevalence occurred after birth, with the lowest levels observed in the <23-month age group, and a steep increase in seroprevalence occurred in early childhood, reaching 60.5% for GI-4, 65.1% for GII-3, and 90.7% for GII-4 at age 2-5 years, and over 80% for all three genotypes in subjects aged 20 years or older. The seroprevalence of different NoV genotypes statistically differed across the age groups (p<0.01).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23627928     DOI: 10.1089/fpd.2012.1300

Source DB:  PubMed          Journal:  Foodborne Pathog Dis        ISSN: 1535-3141            Impact factor:   3.171


  9 in total

Review 1.  Advances in norovirus biology.

Authors:  Stephanie M Karst; Christiane E Wobus; Ian G Goodfellow; Kim Y Green; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

Review 2.  Epidemiology and evolution of Norovirus in China.

Authors:  Na Wei; Jun Ge; Changyao Tan; Yunlong Song; Shiwei Wang; Mengru Bao; Jianqiang Li
Journal:  Hum Vaccin Immunother       Date:  2021-09-08       Impact factor: 4.526

Review 3.  Norovirus vaccines: Correlates of protection, challenges and limitations.

Authors:  Nada M Melhem
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

4.  Seroprevalence of norovirus genogroup IV antibodies among humans, Italy, 2010-2011.

Authors:  Barbara Di Martino; Federica Di Profio; Chiara Ceci; Elisabetta Di Felice; Kim Y Green; Karin Bok; Simona De Grazia; Giovanni M Giammanco; Ivano Massirio; Eleonora Lorusso; Canio Buonavoglia; Fulvio Marsilio; Vito Martella
Journal:  Emerg Infect Dis       Date:  2014-11       Impact factor: 6.883

Review 5.  Norovirus transmission dynamics: a modelling review.

Authors:  K A M Gaythorpe; C L Trotter; B Lopman; M Steele; A J K Conlan
Journal:  Epidemiol Infect       Date:  2017-12-22       Impact factor: 4.434

6.  The First Norovirus Longitudinal Seroepidemiological Study From Sub-Saharan Africa Reveals High Seroprevalence of Diverse Genotypes Associated With Host Susceptibility Factors.

Authors:  Lucy Thorne; Angela Nalwoga; Alexander J Mentzer; Alexis de Rougemont; Myra Hosmillo; Emily Webb; Margaret Nampiija; Allan Muhwezi; Tommy Carstensen; Deepti Gurdasani; Adrian V Hill; Manj S Sandhu; Alison Elliott; Ian Goodfellow
Journal:  J Infect Dis       Date:  2018-07-24       Impact factor: 5.226

7.  Efficient expression of enterovirus 71 based on virus-like particles vaccine.

Authors:  Hye-Jin Kim; Ho Sun Son; Sang Won Lee; Youngsil Yoon; Ji-Yeon Hyeon; Gyung Tae Chung; June-Woo Lee; Jung Sik Yoo
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

8.  Profiling of humoral immune responses to norovirus in children across Europe.

Authors:  Nele Villabruna; Ray W Izquierdo-Lara; Claudia M E Schapendonk; Erwin de Bruin; Felicity Chandler; Tran Thi Nhu Thao; Brenda M Westerhuis; Janko van Beek; Louise Sigfrid; Carlo Giaquinto; Herman Goossens; Julia A Bielicki; Malte Kohns Vasconcelos; Pieter L A Fraaij; Marion P G Koopmans; Miranda de Graaf
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

9.  Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006.

Authors:  Janko van Beek; Miranda de Graaf; Ming Xia; Xi Jiang; Jan Vinjé; Mathias Beersma; Erwin de Bruin; David van de Vijver; Melle Holwerda; Marlies van Houten; Annemarie M Buisman; Rob van Binnendijk; Albert D M E Osterhaus; Fiona van der Klis; Harry Vennema; Marion P G Koopmans
Journal:  J Gen Virol       Date:  2016-06-30       Impact factor: 3.891

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.